No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use
-
Disease Progression
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Drug Therapy, Combination
-
Female
-
Hepatitis C, Chronic / complications*
-
Hepatitis C, Chronic / diagnosis*
-
Hepatitis C, Chronic / drug therapy
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use*
-
Liver Cirrhosis / drug therapy*
-
Liver Cirrhosis / physiopathology
-
Liver Cirrhosis / virology*
-
Liver Function Tests
-
Long-Term Care
-
Male
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins
-
Risk Assessment
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins